Cancer as an infective disease: the role of EVs in tumorigenesis

por Robado de Lope, Lucia, Sánchez‐Herrero, Estela, Serna‐Blasco, Roberto, Provencio, Mariano, Romero, Atocha
Publicado 2022

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis

por Sánchez-Herrero, Estela, Serna-Blasco, Roberto, Robado de Lope, Lucia, González-Rumayor, Víctor, Romero, Atocha, Provencio, Mariano
Publicado 2022

R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies

por Serna-Blasco, Roberto, Sánchez-Herrero, Estela, Berrocal Renedo, María, Calabuig-Fariñas, Silvia, Molina-Vila, Miguel Ángel, Provencio, Mariano, Romero, Atocha
Publicado 2021

Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer

por Cenigaonandia-Campillo, Aiora, Serna-Blasco, Roberto, Gómez-Ocabo, Laura, Solanes-Casado, Sonia, Baños-Herraiz, Natalia, Puerto-Nevado, Laura Del, Cañas, Jose Antonio, Aceñero, María Jesús, García-Foncillas, Jesús, Aguilera, Óscar
Publicado 2021

ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib

por Romero, Atocha, Serna-Blasco, Roberto, Alfaro, Cristina, Sánchez-Herrero, Estela, Barquín, Miguel, Turpin, María Carmen, Chico, Sofía, Sanz-Moreno, Sandra, Rodrigez-Festa, Alejandro, Laza-Briviesca, Raquel, Cruz-Bermudez, Alberto, Calvo, Virginia, Royuela, Ana, Provencio, Mariano
Publicado 2020

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

por Sánchez‐Herrero, Estela, Serna‐Blasco, Roberto, Ivanchuk, Vadym, García‐Campelo, Rosario, Dómine Gómez, Manuel, Sánchez, José M., Massutí, Bartomeu, Reguart, Noemi, Camps, Carlos, Sanz‐Moreno, Sandra, Calabuig‐Fariñas, Silvia, Jantus‐Lewintre, Eloísa, Arnal, Magdalena, Fernández‐Orth, Dietmar, Calvo, Virginia, González‐Rumayor, Víctor, Provencio, Mariano, Romero, Atocha
Publicado 2021

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation

por Serna-Blasco, Roberto, Sánchez-Herrero, Estela, Robado de Lope, Lucía, Sanz-Moreno, Sandra, Rodríguez-Festa, Alejandro, Ares-Trotta, Dunixe, Cruz-Bermúdez, Alberto, Franco, Fabio, Sánchez-Hernández, Alfredo, Campayo, María de Julián, García-Girón, Carlos, Dómine, Manuel, Blasco, Ana, Sánchez, José M., Oramas, Juana, Bosch-Barrera, Joaquim, Sala, María Á., Sereno, María, Romero, Atocha, Provencio, Mariano
Publicado 2022

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlle...

por Provencio, Mariano, Ortega, Ana Laura, Coves-Sarto, Juan, Calvo, Virginia, Marsé-Fabregat, Raquel, Dómine, Manuel, Guirado, María, Carcereny, Enric, Fernández, Natalia, Álvarez, Ruth, Blanco, Remei, León-Mateos, Luis, Sánchez-Torres, José Miguel, Sullivan, Ivana Gabriela, Cobo, Manuel, Sánchez-Hernández, Alfredo, Massuti, Bartomeu, Sierra-Rodero, Belen, Mártinez-Toledo, Cristina, Serna-Blasco, Roberto, Romero, Atocha, Cruz-Bermúdez, Alberto
Publicado 2022

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

por Provencio, Mariano, Serna-Blasco, Roberto, Nadal, Ernest, Insa, Amelia, García-Campelo, M. Rosario, Casal Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodríguez-Abreu, Delvys, Martínez-Martí, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Pereira, Eva, Royuela, Ana, Calvo, Virginia, Martín-López, Javier, García-García, Francisco, Casarrubios, Marta, Franco, Fernando, Sánchez-Herrero, Estela, Massuti, Bartomeu, Cruz-Bermúdez, Alberto, Romero, Atocha
Publicado 2022